Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Acute lymphoblastic leukemia [ALL]
- ICD-10 Code: C91.0
Summary
Acute lymphoblastic leukemia (ALL) is a fast-growing cancer of the blood and bone marrow that affects lymphoid cells, a type of white blood cell. It results from the uncontrolled proliferation of immature lymphoblasts, which crowd out healthy blood cells. This condition can spread to other organs, including the lymph nodes, spleen, and central nervous system.
Causes
The exact cause of ALL is not fully understood, but it involves genetic mutations in lymphoid precursor cells that disrupt normal cell development. Contributing factors may include environmental exposures, genetic predispositions, and previous treatments like chemotherapy or radiation.
Risk Factors
- Exposure to high levels of radiation
- Certain chemical exposures (e.g., benzene)
- Genetic disorders (e.g., Down syndrome)
- Family history of leukemia
- Prior chemotherapy or radiation therapy
- Weakened immune system (e.g., from HIV or immunosuppressive drugs)
Symptoms
- Fatigue and weakness
- Fever or night sweats
- Unexplained weight loss
- Frequent infections
- Easy bruising or bleeding
- Swollen lymph nodes, liver, or spleen
- Bone or joint pain
Diagnosis
Diagnosis involves a physical examination, followed by blood tests to assess cell counts and identify abnormal lymphocytes. A bone marrow biopsy is typically performed to confirm the presence of leukemic cells. Additional tests, such as flow cytometry or genetic analysis, may be used to characterize the leukemia.
Treatment Options
Treatment for ALL often includes chemotherapy to eliminate cancer cells, sometimes followed by stem cell transplantation to restore healthy bone marrow. Targeted therapies or immunotherapies may be used in specific cases. Supportive care, such as blood transfusions or antibiotics, addresses symptoms and complications.
Prognosis and Follow-Up
Prognosis varies based on factors like age, genetic markers, and response to treatment. Regular follow-up appointments monitor for recurrence or long-term effects of therapy. Survival rates have improved with modern treatments, but outcomes depend on individual circumstances.
Complications
- Infections due to low white blood cell counts
- Excessive bleeding from low platelet counts
- Anemia causing fatigue
- Spread of leukemia to the central nervous system
- Side effects from chemotherapy or other treatments
Lifestyle & Prevention
While prevention is not always possible, avoiding known risk factors (e.g., limiting exposure to radiation or chemicals) may reduce risk. Maintaining a healthy lifestyle, including a balanced diet and regular exercise, supports overall well-being during and after treatment.
When to Seek Professional Help
Seek immediate medical attention for symptoms like unexplained bleeding, severe fatigue, persistent fever, or signs of infection. Early evaluation is critical for timely diagnosis and treatment.
Tips for Medical Coders
When coding for C91.0, ensure documentation specifies "acute lymphoblastic leukemia" and confirms the diagnosis. Verify that the code aligns with clinical findings, as ALL is distinguished from other leukemias by its acute onset and lymphoid cell involvement. Accurate coding supports appropriate clinical and administrative workflows.
Medical Policies and Guidelines
Related policies from health plans
C91.0 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.